한국형 양극성 장애 약물치료 알고리듬 2018 : 신체 질환이 동반되었을 경우
- Alternative Title
- Korean Medication Algorithm for Bipolar Disorder 2018 : Medical Comorbidity
- Abstract
- Objectives : The fourth revision of Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was performed in 2018, to provide newer guidelines for clinicians. In this section, we examined expert opinions to facilitate clinical decisions relative to treating bipolar disorder with medical comorbidity.
Methods : The survey was completed by the review committee, consisting of 61 experienced psychiatrists. This part of the survey constitutes treatment strategies, under major medical comorbidities. The executive committee analyzed results, and discussed the final production of algorithm.
Results : Aripiprazole was the first-line medication for bipolar patients with metabolic syndrome, cardiovascular, hepatic, renal, and cerebrovascular comorbidities. Ziprasidone also was recommended as the first-line medication in case of metabolic syndrome. Lithium also was regarded as the first-line medication, in case of hepatic problems. Valproate also was considered as the first-line medication, in case of cerebrovascular problems.
Conclusion : This study provided the most recent consensus among experts, for treatment of bipolar disorder with physical problems.
- All Author(s)
- H. R. Song
; W. M. Bahk
; B. H. Yoon
; D. I. Jon
; J. S. Seo
; W. Kim
; J. G. Lee
; Y. S. Woo
; J. H. Jeong
; M. D. Kim
; I. Sohn
; S. H. Shim
; K. J. Min
- Issued Date
- 2018
- Type
- Article
- Keyword
- Bipolar disorder; Medical comorbidity; Pharmacotherapy; Algorithm
- Publisher
- 대한우울조울병학회
Korean Society for Affective Disorders
- ISSN
- 1738-0960
; 2671-4655
- Citation Title
- Mood and Emotion
- Citation Volume
- 16
- Citation Number
- 3
- Citation Start Page
- 129
- Citation End Page
- 133
- Language(ISO)
- kor
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/2478
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.